1. Introduction {#sec0005}
===============

Endometrial stromal sarcoma (ESS) is a rare mesenchymal tumour of the uterus. It may also arise as a primary extrauterine endometrial sarcoma (EESS), mainly on the background of endometriosis, with predominant gonadal involvement as a result. Very rarely does EESS arise primarily in the gastrointestinal or extra-gastrointestinal tract organs outside the pelvis, or evolve without preceding endometriosis [@bib0005]. In these cases, the non-specific presentation and the unexpected location pose a diagnostic challenge [@bib0010], [@bib0015], and often another abdominal pathology is first suspected. A case of primary EESS arising from omentum mimicking a colonic primary is presented, with review of the literature. This report is line with the SCARE criteria [@bib0020].

2. Presentation of case {#sec0010}
=======================

A 47-year-old female, presented to the Emergency Department with right sided and central abdominal pain. Her medical history included hysterectomy 10 years earlier for menorrhagia, and HRT with oestradiol patch. She reported vague, generalized abdominal pain, mainly central, which later migrated to the right lower abdomen. On examination she was tender along the right and upper central abdomen with localized peritonism. WBC and CRP were elevated (12.1 × 10^9^/L, 16 mg/L respectively). Sonography demonstrated a hypoechoic, ovoid, irregular lesion with blind end, and sonographic probe induced tenderness above it. Given the acute presentation, and the high suspicion for an inflammatory lesion, the patient was taken for an exploratory laparoscopy. At surgery, a firm irregular omental mass was found, located above the proximal transverse colon, near the hepatic flexure. The lesion seemed to extend from the colon. The Appendix was normal. Prior hysterectomy was noted, right ovary and tube were normal, however optimal view of the left adnexa was impossible due to pelvic small bowel adhesions. No other pathology was found. A partially necrotic omental nodule adjacent to the larger eccentric mass was biopsied. The specimen consisted of an 18 × 15 × 12 mm nodule, with extensive haemorrhagic necrosis. The residual tissue was comprised of monomorphic ovoid to spindle-shaped cells with high nuclear to cytoplasmic ratio. The morphology suggested a mesenchymal-type lesion, but immunohistochemistry with a panel of antibodies, raised the possibility of endometrial stromal sarcoma.

Given the rarity of this diagnosis without previous ESS and endometriosis, the past hysterectomy slides were reviewed and confirmed as benign without any evidence of ESS. The current and previous slides were sent for a second external review which supported the diagnosis of primary EESS. A systemic workup was then undertaken. Chest, abdomen and pelvis computed tomography demonstrated a 28 × 15 mm ovoid mass arising from the transverse colon, without evidence for distant metastasis or nodal disease ([Fig. 1](#fig0005){ref-type="fig"}). Tumour markers (CA19.9, CA-125, CEA, AFP) were negative. Colonoscopy excluded primary or secondary colon involvement. The patient was discussed by the Surgical and Gynae-Oncology multidisciplinary teams. The decision was to proceed with laparoscopic excision of the tumour together with BSO by joint surgical and gynaecology teams. A two centimetre omental lesion was found next to the hepatic flexure and resected. Pelvic small bowel loops were adhesiolysed and normal looking ovaries and tubes were resected. No peritoneal spread or other metastatic lesions were identified. The post-operative recovery was uneventful and the patient was discharged on day one post surgery.Fig. 1(Greyscale and colour). Contrast enhancement coronal computed tomography showing showing ovoid mass in proximity to transverse colon.Fig. 1

The omental lesion contained a firm nodule measuring 21 mm in maximal dimension. The mass was characterized by multiple foci of ovoid to spindle--shaped cells forming irregular tongues dissecting through markedly fibroblastic stroma ([Fig. 2](#fig0010){ref-type="fig"}a). The cells were uniform with rare mitotic figures. Small capillary-sized blood vessels were found within the proliferative cells ([Fig. 2](#fig0010){ref-type="fig"}b). The tumour cells stained strongly for CD10 ([Fig. 2](#fig0010){ref-type="fig"}c), oestrogen receptor, progesterone receptor, vimentin, WT-1 and Bcl-2. There was no reaction for c-Kit, CD34, desmin, or smooth muscle actin. Both ovaries and fallopian tubes were normal. The morphology and immunoprofile were compatible with the diagnosis of primary extrauterine low grade ESS originating from the omentum. HRT was ceased and the patient was put on adjuvant hormonal therapy with medroxyprogesterone acetate and was scheduled for regular follow-up.Fig. 2(Colour image). (A) Islands of spindle-shaped tumour cells infiltrating into omental fat. (B) Uniform population of spindle small with embedded prominent capillary-sized vessels/or arterioles. (C) Strong immunoreaction of cells for CD10.Fig. 2

3. Discussion {#sec0015}
=============

Extrauterine endometrial sarcoma involving an extra-genital site is an extremely rare condition. It is even more rare to find it in the upper abdomen and without any clinical evidence of endometriosis. Even fewer cases of upper abdominal ESS without clinical evidence of endometriosis have been described in the literature. All 20 reported cases (including the present case) reported since 1990 were reviewed. These are summarized in [Table 1](#tbl0005){ref-type="table"}.Table 1Clinical features of extaruterine extraovarian abdominopelvic ESS.Table 1AuthorsAge (yr)Past History/HRTPresenting symptomsAbdominal SiteGross FindingsDisseminationAssociated Endometriosis (specimen)TreatmentFollow upSon et al. [@bib0025]52NoneConstipation,\
abdominal pain and hematochezia (1 mo)Sigmoid colon3.5 × 2.8 cm polypoid mass involving whole layers of colonic wall to pericolic fatLocal (pelvic, peritoneum, ovaries)NoLaparoscopic LAR\
TAH, BSO (2mo later)NED,\
4 moWang et al. [@bib0030]40TAH (leiomyoma)\
Rt. Ovarian cystectomyChange in bowel habits and hematochezia\
(1 yr)Rectosigmoid, mesentery, intestinal wallMultiple 1--3 cm nodular masses involving intestinal wall and mesenteryDistant (multiple mesentery and abdominal metastasis)YesIntraoperative chemotherapy, palliative transverse loop colostomyDOD,\
18 moGhosal et al. [@bib0075]42NonePalpable mass (1 mo)Transverse and sigmoid colon mesentery, peritoneumMultiple 0.7--2.8 cm nodular masses involving mesentery and peritoneumDistant (multiple abdominal metastasis, para-aortic LNs)YesTAH, BSO, resection of abdominal nodules, and pelvic and para-aortic nodesNAAyuso et al. [@bib0035]80TAH, BSO (endometriosis/abnormal bleeding)\
HRTHematochesia\
Chronic dischargeSigmoid colon5 cm pelvic mass involving mucosa, muscularis and adjacent peritoneumLocal (peritoneum)NoLaparoscopic AR\
- \> Hormonal therapyNED\
4 yBiliatis et al. [@bib0010]56NoneIncidental finding of a pelvic mass at pelvic USTerminal ileum, cecum8 × 7 × 6 cm mass invading serosaNoneYesRt. Hemicolectomy, TAH, BSO, bilateral pelvic node resection, omentectomy\
- \> Chemotherapy\
- \> Hormonal therapyNED\
38 moRosca et al. [@bib0055]51Removal of endometriosis\
implants from ovaries and rectumNASigmoid,\
Appendix (2 m later)5 cm mass\
3 cm peri-appnedicular massLocalYesResection\
Details NARecurrence\
2 mo\
Long term − NADoghri et al. [@bib0065]45NoneAbdominal discomfort\
(6 mo)Omentum35 × 28 × 18 cm mass involving omentumNoneYesTumourectomy and omentectomyNAZemlyak et al. [@bib0060]70TAH, BSO (leiomyoma)\
Endometriosis\
HRTAbdominal pain and increased urinary frequencySigmoid colon, terminal ileum15.8 × 13 × 8.9 cm mass adherent to both bowel segments and left ureterNoneYesSigmoidectomy and segmental resection of terminal ileumNED\
3 yrKim et al. [@bib0005]75TAH, BSO (leiomyomas)Abdominal pain and palpable mass (1 yr)Jejunum, mesentery and omentum7 cm mass adherent to jejunal serosa.\
4.5 cm mass in jejunal lumen.\
03.-0.5 cm nodules on mesentery and omentum.Local (mesentery,omentum)NoSegmental resection of jejunum and omentectomy\
Refused chemotherapyRecurrence\
5 mo\
repeated surgery, no further F/UChen et al. [@bib0040]42Non-small cell lung cancer, chemotherapy Treatment\
(5 yr)Difficult defecation and hematochezia\
(1 mo)Sigmoid colon and omentum1--3 cm nodular masses involving bowel wall from mucosa to peri-colic fatLocal (omentum, ovary, fallopian tubes)YesRectosigmoidectomy, TAH, BSO, partial omentectomy\
-\> RadiotherapyNED\
12 moKovac et\
al. [@bib0110]45TAH, RSO (leiomyoma, normal adnexa)Symptoms of stenosing processRectosigmoid and omentum6 cm mass infiltrating all layers of bowel wall and multiple omental nodulesLocal (omentum, ovary)YesTumourectomy, colon resection, LSO, omentectomyNED\
11 moRojas et al. [@bib0050]42NoneDiarrhea (2 yr) Acute abdominal pain, small bowel obstruction (1 d)Small bowel, mesentery2.5--3.5 cm multiple nodulesDistant (bowel mesentery)YesLaparoscopy, 3 nodules resected for histology. No definite surgery described.NACho et al. [@bib0045]48Subtotal hysterectomy (leiomyoma)\
TAH, BSO (endometriosis)Difficult defecation and tenesmusSigmoid colon1--3 cm multi-multinodular masses involving all layer of bowel wallLocal (bowel, bladder, ureter)YesSegmental sigmoid resection, regional LNs dissectionDIC post surgery\
NED\
4 moBosincu et al. [@bib0070]42NoneAbdominal pain and feverRectosigmoidMultiple polypoid ulcerated masses with transmural infiltration of bowel wall (size NA)Local (omentum, peritoneum, parametrium, paracolic LNs)YesAR, appendectomy, omentectomy, TAH, BSO\
-\> ChemotherapyNED\
20 moMourra et al. [@bib0085]61HRTEpigastric pain (portal vein thrombosis on US)Rectosigmoid2.7 cm polypoid tumour with lumen stenosis, involving all layers of bowel wallNoneYesLARNED\
30 moYantiss et al. [@bib0090]63NANARectum2 cm polypoid mass involving all layers of bowel wall with lumen stenosisNoneYesRectal resection (not specified)Recurrence 3y.\
NED at 6y following radiotherapyFukunaga et al. [@bib0115]43NoneAbdominal distention\
(1 mo)Rectum, bladder14 × 12 × 10 cm ill-circumscribed mass adherent to rectum and bladder wallNoneYesTumourectomy, partial resection of rectal wall, TAH, BSONED\
39 moFukunaga et al. [@bib0115]50NoneAbdominal distensionOmentum, transverse colon mesentery20 cm omental mass, 10 cm mesocolon massLocal (mesentery)NoTumourectomy, partial resection of transverse colonNED\
18 moBaiocchi et al. [@bib0080]38Ovarian Cystectomy (endometriosis)\
TAH, BSO (menorrhagia)Abdominal and back pain\
(6 mo)Transverse and ascending colon, terminal ileumLarge multilobular mass adherent to colon and ileum, with scattered implants (size NA)Distant (falciform ligament, gastrocolic ligament mesentery, pelvis)YesColectomy (ascending and transverse colon), partial ileum resection\
-\> Chemotherapy\
-\> Hormonal therapyNED\
2yPresent case47TAH\
(menorrhagia)\
HRTAcute RLQ abdominal painOmentum2.1 cm tumour embedded in omentumNoneNoLaparoscopic resection of tumour, BSO\
-\> Hormonal therapyNED\
6 mo[^2]

Patient ages ranges between 38--80 years (median, 47.5 years). More than half of the patients were in their fifth decade or early menopause years (11/20) as previously reported [@bib0015]. The clinical presentation was ambiguous in most instances. The commonest complaint was abdominal pain (9 cases). Other complaints included hematochezia (4 cases) [@bib0025], [@bib0030], [@bib0035], [@bib0040], change in bowel habits (4 cases) [@bib0025], [@bib0030], [@bib0040], [@bib0045], and tenesmus (1 case) [@bib0045]. Only 2 cases, including the current one, presented acutely and were diagnosed following an emergent surgical intervention [@bib0050]. Associated foci of endometriosis was found in proximity to the tumour in 16 out of 20 patients, but only 3 of the 16 had documented history of endometriosis [@bib0045], [@bib0055], [@bib0060]. One patient had past endometriosis but none was found near the tumour [@bib0035]. The rectosigmoid was the most common site for primary EESS (12/20). Solitary involvement of the omentum is rare and was reported only in one case report prior to ours [@bib0065]. Lesions in the gastrointestinal tract may involve the serosa (9 cases) or invade bowel wall to create polypoid lesions [@bib0070], with resulting carcinoma-like obstructive symptoms (8 cases). Only four patients presented with disseminated disease [@bib0030], [@bib0050], [@bib0075], [@bib0080], while localised lesion or local spread comprised the majority of cases (9 and 7 cases respectively). Eight women had previous hysterectomy for benign pathologies, and four received unopposed hormonal therapy at the time of diagnosis, including the present case [@bib0035], [@bib0060], [@bib0085].

The association of EESS with endometriosis provides a clue for the pathogenesis of this tumour. Malignant transformation of endometriosis is a rare but recognised phenomenon, and was demonstrated by Yantiss et al. who reviewed 17 cases of pre-malignant and malignant transformation of gastrointestinal endometriosis [@bib0090]. Most malignant tumours were endometrial adenocarcinomas (8 cases), with one case of EESS. The high prevalence of concomitant endometriosis may have a bearing on the transformation pathway for EESS [@bib0015]. The pathogenesis of EESS in the absence of ectopic endometrial stroma is more obscure. Possible explanations include gland-poor endometriosis foci (stromal endometriosis) or complete replacement by the tumour [@bib0015]. Another theory is de-novo malignant transformation of peritoneum or coelomic multipotential epithelial cells [@bib0005], [@bib0015], [@bib0095].

Unopposed hormonal therapy is associated with endometrial carcinomatosis and is related to EESS as well [@bib0090]. Masand et al. found that the majority of postmenopausal women diagnosed with EESS and associated endometriosis were on long standing HRT [@bib0015]. In the present review four women received HRT, including the present case. Associated endometrial foci were found in two of those cases. No endometriosis was found in the third case, although there was a clinical history of endometriosis. The present case had neither past endometriosis nor pathological evidence of it in the resected specimen. This is the only reported case with EESS on the background of prolonged HRT without history or clinical presence of endometriosis. These findings suggest that HRT may be an independent risk factor for development and/or progression of EESS [@bib0015], [@bib0090].

Diagnosis of primary EESS needs exclusion of a uterine primary. In women with previous hysterectomy for benign pathologies, it is crucial to review previous specimens and rule out a missed uterine primary. The main differential diagnosis for EESS when arising from bowel is some other mesenchymal tumours, especially gastrointestinal stromal tumours (GISTs). Spindle cells in EESS are characterised by monotonous arrangement, compared with sheets or fascicles arrangement in GIST. Proliferation of small arterioles, resembling spiral arterioles of the endometrium, is also typical of EESS. However, the final diagnosis, especially in cases of unusual tumour location and absence of endometriosis, depends on immunohistochemistry. Positive labelling for CD10, PR and ER with no reactivity for CD117 and CD34 confirms the diagnosis [@bib0005], [@bib0015], [@bib0100].

Although EESS was previously believed to have worse prognosis than its uterine counterpart [@bib0105], accumulating evidence, does not support this. Most cases reviewed had multifocal disease, with either local or distant dissemination, while only one death was reported for a patient with unresectable low grade EESS [@bib0030]. The clinical behaviour of EESS is similar to low grade uterine ESS. Mitotic index, size, multifocality, and vascular invasion, the known predictors for worse prognosis, do not affect the patients' outcomes. The only feature that may predict poorer prognosis is high grade histologic features namely de-differentiation or cytologic atypia. This includes loss of typical vascular pattern, pleomorphic spindle or epitheloid cells, in concurrence with brisk mitotic activity [@bib0015].

Given the rarity of EESS, the treatment is usually based on the guidelines for uterine ESS. Surgical resection with or without debulking is the cornerstone of EESS treatment. Total abdominal hysterectomy and BSO is often added in order to rule out uterine or ovarian primary. The value of adjuvant therapy is not clear, as no prospective studies exist. Treatment options include observation only, hormonal therapy, chemotherapy, radiotherapy, or combined modality treatment. Hormonal therapy is the most prevalent treatment, and was also the chosen treatment for the present case [@bib0015], [@bib0060], [@bib0100].

4. Conclusion {#sec0020}
=============

EESS can occur without endometriosis and HRT may be an independent aetiological factor. The condition can mimic a chronic or acute abdominal pathology and laparoscopic core biopsy is the best way to achieve a diagnosis and formulate management.
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[^1]: Present address: Upper Gastrointestinal and Hepatobiliary Unit, Department of Surgery, The Lyell McEwin Hospital, Haydown Rd, Elizabeth Vale, SA 5112, Australia.

[^2]: TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; RSO, rt. salpingo-oophorectomy; HRT, hormonal replacement therapy; NA, not available; NED, no evidence of disease; DOD, dead of disease.
